• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Cogent Biosciences, Inc. - Common Stock (NQ:COGT)

    38.05 +2.14 (+5.96%)
    Streaming Delayed Price Updated: 2:48 PM EST, Feb 2, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,043,598
    Open 36.45
    Bid (Size) 38.03 (300)
    Ask (Size) 38.07 (100)
    Prev. Close 35.91
    Today's Range 36.23 - 38.15
    52wk Range 3.720 - 43.73
    Shares Outstanding 85,465,249
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Large Biotech Fund Sells Shares of Cogent Biosciences for Over $120M ↗
    A large biotech fund that's an insider at Cogent Biosciences recently sold millions of shares amid the company's best annual performance ever in 2025. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Cogent Insider Sells $2.5 Million in Stock Amid Staggering 300% Price Surge ↗
    Focused on precision therapies for rare diseases, this biotech firm reported a significant insider sale amid a year of sharp share gains. 
    Via The Motley Fool
    Topics Regulatory Compliance

    Performance

    YTD
    +9.5%
    +9.5%
    1 Month
    +9.5%
    +9.5%
    3 Month
    +145.5%
    +145.5%
    6 Month
    +215.8%
    +215.8%
    1 Year
    +323.2%
    +323.2%

    More News

    Read More
    What's going on in today's after hours session ↗
    Via Chartmill
    News headline image
    This Biotech Fund Just Made a $22 Million Bet on Pharvaris Stock — Is It a Buy? ↗
    Via The Motley Fool
    News headline image
    Hedge Fund Boosts Stake in Amylyx Stock to $63 Million — Should Investors Follow? ↗
    Via The Motley Fool
    News headline image
    Why a Biotech Fund Made Dyne Therapeutics One of Its Biggest Stock Bets ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    With a 150% Rally and Big 2026 Catalysts Ahead, Is Amylyx Stock Getting a Second Chance? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Scholar Rock Stock Is Still Down 40% From 2021 Highs — And One Investor Just Walked Away ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Terns Stock Surges 300% in One Year — What a New $43 Million Position Signals for Investors ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Relay Therapeutics Stock Has Jumped 60% in a Year — And One Investor Just Bought Nearly 4 Million More Shares ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    This Biotech Fund Has an $85 Million Bet on Amylyx as Stock Surges 180% and Co-CEOs Tease 'Transformational' Year Ahead ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    This Biotech Fund Made a New $40 Million Bet on Liquidia Amid Blockbuster Commercial Drug Launch ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Centessa Stock Has Surged 77% Over the Past Year — But a Top Biotech Fund Is Still Buying ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    This Fund Sold $49 Million of Cidara Stock — Then Merck Announced a $9.2 Billion Takeover ↗
    Via The Motley Fool
    News headline image
    Top movers analysis one hour before the close of the markets on 2025-11-10: top gainers and losers in today's session. ↗
    Via Chartmill
    News headline image
    Top movers in Monday's session ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Monday's Intraday Session ↗
    Via Benzinga
    News headline image
    Gold Jumps Over 2%; Dole Shares Gain After Q3 Results ↗
    Via Benzinga
    News headline image
    Cogent Biosciences Hits 7-Year High, Up 120% On Its New Stomach Cancer Promise ↗
    Via Investor's Business Daily
    News headline image
    Let's uncover which stocks are experiencing notable gaps during today's session. ↗
    Via Chartmill
    News headline image
    Cogent Biosciences' Lead Cancer Drug Cuts Disease Progression Or Death Risk By 50% In Stomach Cancer Trial ↗
    Via Benzinga
    News headline image
    Pagaya Technologies Posts Upbeat Q3 Results, Joins Ironwood Pharmaceuticals, TreeHouse Foods And Other Big Stocks Moving Higher On Monday ↗
    Via Benzinga
    News headline image
    S&P 500 Surges 1%; Tyson Foods Posts Upbeat Earnings ↗
    Via Benzinga
    Topics Stocks
    News headline image
    Monday's pre-market session: top gainers and losers ↗
    Via Chartmill
    News headline image
    Cogent Biosciences Soars to 52-Week High on "Breakthrough" Systemic Mastocytosis Trial Results
    Via MarketMinute
    Topics Economy Supply Chain

    Frequently Asked Questions

    Is Cogent Biosciences, Inc. - Common Stock publicly traded?
    Yes, Cogent Biosciences, Inc. - Common Stock is publicly traded.
    What exchange does Cogent Biosciences, Inc. - Common Stock trade on?
    Cogent Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Cogent Biosciences, Inc. - Common Stock?
    The ticker symbol for Cogent Biosciences, Inc. - Common Stock is COGT on the Nasdaq Stock Market
    What is the current price of Cogent Biosciences, Inc. - Common Stock?
    The current price of Cogent Biosciences, Inc. - Common Stock is 38.05
    When was Cogent Biosciences, Inc. - Common Stock last traded?
    The last trade of Cogent Biosciences, Inc. - Common Stock was at 02/02/26 02:48 PM ET
    What is the market capitalization of Cogent Biosciences, Inc. - Common Stock?
    The market capitalization of Cogent Biosciences, Inc. - Common Stock is 3.25B
    How many shares of Cogent Biosciences, Inc. - Common Stock are outstanding?
    Cogent Biosciences, Inc. - Common Stock has 3B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.